BusinessBiota Pharmaceuticals to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare ConferenceBy Nasdaq OMXDec 11, 2015, 9:02 PM UTC
BusinessMersana Therapeutics' Lead Immunoconjugate Continues to Demonstrate Complete Tumor Regressions in Multiple HER2-Expressing Breast Cancer Tumor ModelsBy Nasdaq OMXDec 11, 2015, 3:03 PM UTC
BusinessKite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional SharesBy Nasdaq OMXDec 11, 2015, 1:01 PM UTC
BusinessCytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166By Nasdaq OMXDec 11, 2015, 1:01 PM UTC
BusinessXBiotech Announces Agreement With the NCIC Clinical Trials Group to Collaborate on Phase II Study in Non-Small Cell Lung Cancer (NSCLC)By Nasdaq OMXDec 11, 2015, 1:01 PM UTC
BusinessOtonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement SurgeryBy Nasdaq OMXDec 11, 2015, 12:31 PM UTC
BusinessGalena Biopharma Announces Departure of Chief Financial OfficerBy Nasdaq OMXDec 11, 2015, 12:06 PM UTC
BusinessZIOPHARM to Host Corporate Update and 2016 Outlook Conference Call on Wednesday, December 16, 2015 at 4:30 PM ETBy Nasdaq OMXDec 11, 2015, 12:01 PM UTC
